Together we will lead Canada’s contribution to global ALS research, as we work toward a world free of ALS.
Finding new treatments that can change the course of ALS requires a robust research program.
Our Research Program funds top peer-reviewed research in Canada, including fundamental and clinical research aimed at better understanding the disease, identifying new therapeutic targets and treatments, and improving clinical management and quality of life. Additionally, we support the best early-career researchers and clinicians working on leading ALS science and patient care.
different programs
ALS-focused grants and awards funded
investigators supported from
different institutions
The Research Program has also funded multiple initiatives of national importance and scope, while considering Canada’s contribution to the global effort to understand and treat ALS.
Key funding areas
Learn more about what studies & initiatives we invest in:
We are proud to have invested $57.5 million in ALS research across Canada and internationally.
These funds pave the way for a better understanding of ALS, supporting researchers in developing effective treatments, and improving quality of life for those living with the disease.
We are proud to have invested $57.5 million in ALS research across Canada and internationally.
These funds pave the way for a better understanding of ALS, supporting researchers in developing effective treatments, and improving quality of life for those living with the disease.
Peer-Review Process
How do we decide which ALS research studies to invest in?
ALS Canada uses a comprehensive peer-review process to decide which projects receive funding, ensuring that donor dollars will have the maximum impact to advance learning in the field.
Opportunities like the ALS Canada Research Program are vital to support researchers early in their careers, to pursue new avenues of research, and advance our understanding of ALS. This support will allow me to investigate a fundamental mechanism that may contribute to ALS, which hasn’t been studied before and enhance my opportunities to become an independent researcher to continue cutting-edge ALS research.
Dr. Philip McGoldrick • 2022 Career Transition Award recipient
Research Impact
Our funding success stories
Investing in this work, with the generous support of our donors, is critical for us to keep moving the needle closer to more effective ways of helping ALS people live longer and better lives.
